GlassScriptPhysician profile
Felicia Edwards
NPI 1538405980
$322.92
in general payments reported to CMS, 2019-2025
11 companies · $13.50 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $45.04 · 2024: $264 · 2025: $13.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $73.87 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $48.81 | 2024 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $37.47 | 2024 | Trelegy Ellipta |
| Pfizer INC. | $36.25 | 2024 | |
| Coherus Oncology, INC. | $29.59 | 2023 | |
| Phathom Pharmaceuticals, INC. | $23.13 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $16.53 | 2024 | |
| Genentech USA, INC. | $15.45 | 2023 | Tecentriq |
| Dynavax Technologies Corporation | $14.74 | 2024 | Heplisav-B |
| Novo Nordisk INC | $13.58 | 2024 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $13.50 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.